Introduction to Nanomedicine, 7.5 credits

Academic year 2023/2024

  • Autumn 2023, 100%, Campus

    Start date: 29 November 2023

    End date: 14 January 2024

    Application deadline: 17 April 2023

    Application code: UU-39005 Application

    Language of instruction: English

    Location: Uppsala

    Selection: Higher education credits in science and engineering (maximum 240 credits)

    Registration: 22 November 2023 – 29 November 2023

Entry requirements: 150 credits, including 120 credits in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering. Previous studies must include (1) physical chemistry and pharmaceutics 13 credits or (2) Molecular Biopharmaceutics 7.5 credits.

Proficiency in English equivalent to the Swedish upper secondary course English 6.


If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application or tuition fees. Formal exchange students will be exempted from tuition fees, as well as the application fee. Read more about fees.

Application fee: SEK 900

Tuition fee, first semester: SEK 18,125

Tuition fee, total: SEK 18,125

About the course

The course covers the principles in nanomedicine, especially with regard to the connection between the physicochemical properties of nanomaterials, possible administration routes and their interactions with cells and tissues in the body. Further, it deals with the behaviour of nanoparticles in biological fluids (e.g. plasma, intestinal fluid) and colloidal stability.

We study the basic principles for active (with ligands) and passive (e.g. for cancer therapy) targeting and uptake of nanoparticles in cells and tissues in the body. Furthermore, the course will cover nanoparticle and nanocarrier properties including the most important synthesis routes and characterisation methods. The special focus is also on diagnostic materials that can be used in imaging techniques or in theranostic formulations that combine disease diagnosis and therapy.

Finally, we will consider the toxic, pharmacokinetic and regulatory aspects of nanomaterials in biomedical applications. For toxicity, this includes a comparison of different external barriers that are exposed to nanomaterials, e.g. in the intestine, lungs, nose and skin.

More information


Department of Pharmacy

Biomedicinskt Centrum BMC, Husargatan 3 752 37 Uppsala

Box 580, 751 23 UPPSALA

Per Larsson